NKTR Covered Call Strategy
NKTR (Nektar Therapeutics), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Nektar Therapeutics is a biopharmaceutical firm dedicated to the global discovery and advancement of therapies addressing significant unmet medical requirements. Central to its robust pipeline is Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist. This drug is currently in Phase 3 clinical trials for metastatic melanoma, renal cell carcinoma, muscle-invasive bladder cancer, head and neck squamous cell carcinoma, and adjuvant melanoma. It is also being evaluated in Phase 2 for renal cell carcinoma, non-small cell lung cancer, and urothelial cancer; Phase 1/2A for head and neck squamous cell carcinoma; Phase 1/2 for various solid tumors; and Phase 1B for COVID-19. Additionally, Nektar is developing NKTR-358, a cytokine Treg stimulant, which is in Phase 2 trials for systemic lupus erythematosus and ulcerative colitis, and Phase 1B for atopic dermatitis and psoriasis. Their portfolio further includes NKTR-255, an IL-15 receptor agonist, undergoing Phase 1/2 trials for non-Hodgkin's lymphoma, multiple myeloma, head and neck cancer, and colorectal cancer.
NKTR (Nektar Therapeutics) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $2.09B, a beta of 1.16 versus the broader market, a 52-week range of 25.34-109, average daily share volume of 1.0M, a public-listing history dating back to 1994, approximately 63 full-time employees. These structural characteristics shape how NKTR stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.16 places NKTR roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a covered call on NKTR?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
NKTR snapshot
As of August 14, 2026, spot at $73.31, ATM IV 68.00%, IV rank 14.06%, expected move 19.50%. The covered call on NKTR below is built from the August 14, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 7-day expiry.
Why this covered call structure on NKTR specifically: NKTR IV at 68.00% is on the cheap side of its 1-year range, which means a premium-selling NKTR covered call collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 19.50% (roughly $14.29 on the underlying). The 7-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated NKTR expiries trade a higher absolute premium for lower per-day decay. Position sizing on NKTR should anchor to the underlying notional of $73.31 per share and to the trader's directional view on NKTR stock.
NKTR covered call setup
The NKTR covered call below is built from the August 14, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With NKTR at $73.31 on that close, the first option leg uses a $75.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed NKTR chain at a 7-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 NKTR shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $73.31 | long |
| Sell 1 | Call | $75.00 | $1.63 |
NKTR covered call risk and reward
- Net Premium / Debit
- -$7,168.50
- Max Profit (per contract)
- $331.50
- Max Loss (per contract)
- -$7,167.50
- Breakeven(s)
- $71.69
- Risk / Reward Ratio
- 0.046
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
NKTR covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on NKTR. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$7,167.50 |
| $16.22 | -77.9% | -$5,546.69 |
| $32.43 | -55.8% | -$3,925.87 |
| $48.63 | -33.7% | -$2,305.06 |
| $64.84 | -11.6% | -$684.24 |
| $81.05 | +10.6% | +$331.50 |
| $97.26 | +32.7% | +$331.50 |
| $113.47 | +54.8% | +$331.50 |
| $129.68 | +76.9% | +$331.50 |
| $145.88 | +99.0% | +$331.50 |
When traders use covered call on NKTR
Covered calls on NKTR are an income strategy run on existing NKTR stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
NKTR thesis for this covered call
The market-implied 1-standard-deviation range for NKTR extends from approximately $59.02 on the downside to $87.60 on the upside. A NKTR covered call collects premium on an existing long NKTR position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether NKTR will breach that level within the expiration window. Current NKTR IV rank near 14.06% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on NKTR at 68.00%. As a Healthcare name, NKTR options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to NKTR-specific events.
NKTR covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. NKTR positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move NKTR alongside the broader basket even when NKTR-specific fundamentals are unchanged. Short-premium structures like a covered call on NKTR carry tail risk when realized volatility exceeds the implied move; review historical NKTR earnings reactions and macro stress periods before sizing. Always rebuild the position from current NKTR chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on NKTR?
- A covered call on NKTR is the covered call strategy applied to NKTR (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With NKTR stock at $73.31 on the August 14, 2026 close, the strikes shown on this page are snapped to the nearest listed NKTR chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are NKTR covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the NKTR covered call priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 68.00%), the computed maximum profit is $331.50 per contract and the computed maximum loss is -$7,167.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a NKTR covered call?
- The breakeven for the NKTR covered call priced on this page is roughly $71.69 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The NKTR market-implied 1-standard-deviation expected move in the same options snapshot is approximately 19.50%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on NKTR?
- Covered calls on NKTR are an income strategy run on existing NKTR stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current NKTR implied volatility affect this covered call?
- NKTR ATM IV is at 68.00% with IV rank near 14.06%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.